nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP4F2—cardial valve—dilated cardiomyopathy	0.353	0.629	CbGeAlD
Fingolimod—S1PR3—cardiac ventricle—dilated cardiomyopathy	0.0264	0.047	CbGeAlD
Fingolimod—S1PR3—myocardium—dilated cardiomyopathy	0.0248	0.0442	CbGeAlD
Fingolimod—S1PR4—heart—dilated cardiomyopathy	0.0248	0.0442	CbGeAlD
Fingolimod—CYP4F12—cardiac ventricle—dilated cardiomyopathy	0.0221	0.0394	CbGeAlD
Fingolimod—CYP4F12—myocardium—dilated cardiomyopathy	0.0208	0.037	CbGeAlD
Fingolimod—S1PR3—heart—dilated cardiomyopathy	0.0173	0.0308	CbGeAlD
Fingolimod—S1PR1—heart—dilated cardiomyopathy	0.0153	0.0272	CbGeAlD
Fingolimod—SPHK1—heart—dilated cardiomyopathy	0.0151	0.0269	CbGeAlD
Fingolimod—S1PR3—cardiac atrium—dilated cardiomyopathy	0.0148	0.0264	CbGeAlD
Fingolimod—CYP4F12—heart—dilated cardiomyopathy	0.0145	0.0258	CbGeAlD
Fingolimod—CYP4F12—cardiac atrium—dilated cardiomyopathy	0.0124	0.0221	CbGeAlD
Fingolimod—Atrioventricular block complete—Lisinopril—dilated cardiomyopathy	0.00505	0.0866	CcSEcCtD
Fingolimod—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.00359	0.0615	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.00277	0.00728	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.00277	0.00728	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—RAC1—dilated cardiomyopathy	0.00275	0.00723	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—RAC1—dilated cardiomyopathy	0.00275	0.00721	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00272	0.00715	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00266	0.00699	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00266	0.00699	CbGpPWpGaD
Fingolimod—SPHK1—Signaling by VEGF—RAC1—dilated cardiomyopathy	0.0026	0.00682	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00256	0.00673	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00256	0.00673	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00256	0.00673	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00256	0.00673	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00247	0.0065	CbGpPWpGaD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—RAC1—dilated cardiomyopathy	0.00243	0.00638	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.0024	0.0063	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00238	0.00626	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00238	0.00626	CbGpPWpGaD
Fingolimod—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00234	0.0402	CcSEcCtD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00233	0.00611	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00233	0.00611	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00231	0.00606	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00231	0.00606	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00216	0.00568	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00209	0.0055	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ANKRD1—dilated cardiomyopathy	0.00205	0.00538	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00205	0.00538	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00203	0.00532	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00203	0.00532	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00197	0.00518	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00197	0.00518	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00195	0.00513	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00195	0.00513	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00195	0.00513	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00195	0.00513	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00194	0.0051	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—TAZ—dilated cardiomyopathy	0.00193	0.00506	CbGpPWpGaD
Fingolimod—Alopecia—Spironolactone—dilated cardiomyopathy	0.00192	0.0329	CcSEcCtD
Fingolimod—S1PR4—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00188	0.00495	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00187	0.00491	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00187	0.00491	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00182	0.00479	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—RAF1—dilated cardiomyopathy	0.00182	0.00479	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—RAF1—dilated cardiomyopathy	0.00182	0.00478	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00181	0.00476	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00181	0.00476	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00181	0.00476	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00179	0.0047	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00177	0.00465	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00177	0.00465	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00177	0.00464	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00176	0.00461	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00176	0.00461	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00174	0.00458	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00174	0.00458	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—SDHA—dilated cardiomyopathy	0.00174	0.00457	CbGpPWpGaD
Fingolimod—SPHK1—Signaling by VEGF—RAF1—dilated cardiomyopathy	0.00172	0.00452	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.0017	0.00446	CbGpPWpGaD
Fingolimod—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00169	0.029	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—TAZ—dilated cardiomyopathy	0.00166	0.00437	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00165	0.00433	CbGpPWpGaD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—RAF1—dilated cardiomyopathy	0.00161	0.00423	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00159	0.00419	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00158	0.00416	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00156	0.00409	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ANKRD1—dilated cardiomyopathy	0.00152	0.00399	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—SDHA—dilated cardiomyopathy	0.0015	0.00395	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.0015	0.00394	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.0015	0.00394	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00148	0.00388	CbGpPWpGaD
Fingolimod—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00145	0.0038	CbGpPWpGaD
Fingolimod—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00145	0.0248	CcSEcCtD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00144	0.00378	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—TAZ—dilated cardiomyopathy	0.00143	0.00375	CbGpPWpGaD
Fingolimod—Eczema—Lisinopril—dilated cardiomyopathy	0.00143	0.0244	CcSEcCtD
Fingolimod—S1PR5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00142	0.00374	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00142	0.00374	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00139	0.00364	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00139	0.00364	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00136	0.00358	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00133	0.0228	CcSEcCtD
Fingolimod—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00131	0.0224	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00129	0.0034	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—SDHA—dilated cardiomyopathy	0.00129	0.00339	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00126	0.00331	CbGpPWpGaD
Fingolimod—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00122	0.0209	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00115	0.00301	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00115	0.00301	CbGpPWpGaD
Fingolimod—Influenza—Lisinopril—dilated cardiomyopathy	0.00111	0.019	CcSEcCtD
Fingolimod—Eye disorder—Furosemide—dilated cardiomyopathy	0.0011	0.0189	CcSEcCtD
Fingolimod—S1PR5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.0011	0.0029	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.0011	0.0029	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.0011	0.0029	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.0011	0.0029	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—AGT—dilated cardiomyopathy	0.0011	0.00288	CbGpPWpGaD
Fingolimod—Pruritus—Spironolactone—dilated cardiomyopathy	0.00109	0.0187	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.00109	0.00286	CbGpPWpGaD
Fingolimod—Angiopathy—Furosemide—dilated cardiomyopathy	0.00107	0.0184	CcSEcCtD
Fingolimod—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00107	0.0182	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00106	0.0028	CbGpPWpGaD
Fingolimod—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00106	0.0181	CcSEcCtD
Fingolimod—S1PR3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00106	0.00277	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00106	0.00277	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00104	0.00273	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00104	0.00273	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00103	0.00271	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00102	0.00269	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00102	0.00269	CbGpPWpGaD
Fingolimod—Dizziness—Spironolactone—dilated cardiomyopathy	0.00102	0.0175	CcSEcCtD
Fingolimod—Weight decreased—Lisinopril—dilated cardiomyopathy	0.001	0.0172	CcSEcCtD
Fingolimod—S1PR5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.001	0.00263	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.001	0.00263	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.001	0.00263	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.001	0.00263	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.001	0.00263	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.001	0.00263	CbGpPWpGaD
Fingolimod—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.000994	0.00261	CbGpPWpGaD
Fingolimod—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000993	0.017	CcSEcCtD
Fingolimod—S1PR5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000993	0.00261	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000993	0.00261	CbGpPWpGaD
Fingolimod—Depression—Lisinopril—dilated cardiomyopathy	0.000985	0.0169	CcSEcCtD
Fingolimod—Vision blurred—Furosemide—dilated cardiomyopathy	0.000969	0.0166	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000967	0.00254	CbGpPWpGaD
Fingolimod—Headache—Spironolactone—dilated cardiomyopathy	0.000967	0.0166	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000959	0.00252	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—ACE—dilated cardiomyopathy	0.000941	0.00247	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000936	0.00246	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000931	0.00245	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000931	0.00245	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000931	0.00244	CbGpPWpGaD
Fingolimod—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000926	0.0159	CcSEcCtD
Fingolimod—Leukopenia—Furosemide—dilated cardiomyopathy	0.000921	0.0158	CcSEcCtD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000917	0.00241	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000909	0.00239	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000909	0.00239	CbGpPWpGaD
Fingolimod—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000902	0.0155	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000901	0.00237	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000901	0.00237	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000901	0.00237	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000893	0.00235	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000881	0.00231	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00087	0.0149	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000848	0.00223	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000848	0.00223	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000845	0.00222	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000835	0.00219	CbGpPWpGaD
Fingolimod—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000823	0.0141	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000819	0.00215	CbGpPWpGaD
Fingolimod—Skin disorder—Furosemide—dilated cardiomyopathy	0.000815	0.014	CcSEcCtD
Fingolimod—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000804	0.0138	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000804	0.00211	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000804	0.00211	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000804	0.00211	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.0008	0.0021	CbGpPWpGaD
Fingolimod—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000799	0.0137	CcSEcCtD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000788	0.00207	CbGpPWpGaD
Fingolimod—Hypotension—Furosemide—dilated cardiomyopathy	0.000784	0.0134	CcSEcCtD
Fingolimod—Alopecia—Lisinopril—dilated cardiomyopathy	0.000783	0.0134	CcSEcCtD
Fingolimod—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000777	0.0133	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00077	0.00202	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00077	0.00202	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00077	0.00202	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000767	0.00202	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000759	0.00199	CbGpPWpGaD
Fingolimod—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000754	0.0129	CcSEcCtD
Fingolimod—Back pain—Lisinopril—dilated cardiomyopathy	0.000746	0.0128	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00073	0.00192	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00073	0.00192	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00073	0.00192	CbGpPWpGaD
Fingolimod—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000727	0.0125	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000725	0.0124	CcSEcCtD
Fingolimod—Fatigue—Furosemide—dilated cardiomyopathy	0.000724	0.0124	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000699	0.00184	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000692	0.00182	CbGpPWpGaD
Fingolimod—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000691	0.0118	CcSEcCtD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000691	0.00181	CbGpPWpGaD
Fingolimod—Palpitations—Lisinopril—dilated cardiomyopathy	0.000682	0.0117	CcSEcCtD
Fingolimod—Cough—Lisinopril—dilated cardiomyopathy	0.000673	0.0115	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000666	0.00175	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000666	0.00175	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000663	0.00174	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000652	0.0112	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000649	0.0017	CbGpPWpGaD
Fingolimod—Infection—Lisinopril—dilated cardiomyopathy	0.000626	0.0107	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000624	0.00164	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000624	0.00164	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00062	0.00163	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000614	0.00161	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000614	0.00161	CbGpPWpGaD
Fingolimod—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000612	0.0105	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000605	0.00159	CbGpPWpGaD
Fingolimod—Asthenia—Furosemide—dilated cardiomyopathy	0.000602	0.0103	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—AGT—dilated cardiomyopathy	0.000597	0.00157	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000597	0.00157	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000597	0.00157	CbGpPWpGaD
Fingolimod—Pruritus—Furosemide—dilated cardiomyopathy	0.000594	0.0102	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000591	0.00155	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000591	0.00155	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000591	0.00155	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000591	0.00155	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000589	0.00155	CbGpPWpGaD
Fingolimod—Hypotension—Lisinopril—dilated cardiomyopathy	0.000589	0.0101	CcSEcCtD
Fingolimod—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000574	0.00984	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000571	0.0015	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000567	0.00149	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000567	0.00149	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000567	0.00149	CbGpPWpGaD
Fingolimod—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000566	0.00969	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000563	0.00148	CbGpPWpGaD
Fingolimod—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000561	0.00962	CcSEcCtD
Fingolimod—Dizziness—Furosemide—dilated cardiomyopathy	0.000555	0.00951	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000553	0.00145	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00055	0.00144	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00055	0.00144	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000544	0.00932	CcSEcCtD
Fingolimod—Fatigue—Lisinopril—dilated cardiomyopathy	0.000543	0.0093	CcSEcCtD
Fingolimod—S1PR5—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000542	0.00142	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000542	0.00142	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000542	0.00142	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000537	0.00141	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000537	0.00141	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000535	0.00141	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000532	0.0014	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000532	0.0014	CbGpPWpGaD
Fingolimod—Headache—Furosemide—dilated cardiomyopathy	0.000526	0.00901	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000515	0.00135	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000499	0.00131	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000492	0.00129	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000484	0.00127	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000475	0.00125	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000475	0.00125	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GPX1—dilated cardiomyopathy	0.000473	0.00124	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000472	0.00124	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—CD36—dilated cardiomyopathy	0.000461	0.00121	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000455	0.00119	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000455	0.00119	CbGpPWpGaD
Fingolimod—Asthenia—Lisinopril—dilated cardiomyopathy	0.000452	0.00774	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000448	0.00118	CbGpPWpGaD
Fingolimod—Pruritus—Lisinopril—dilated cardiomyopathy	0.000446	0.00763	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000442	0.00116	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000431	0.00113	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000431	0.00113	CbGpPWpGaD
Fingolimod—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000431	0.00738	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000428	0.00112	CbGpPWpGaD
Fingolimod—Dizziness—Lisinopril—dilated cardiomyopathy	0.000416	0.00714	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—AGT—dilated cardiomyopathy	0.000415	0.00109	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000413	0.00108	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GPX1—dilated cardiomyopathy	0.000408	0.00107	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CD36—dilated cardiomyopathy	0.000398	0.00104	CbGpPWpGaD
Fingolimod—Headache—Lisinopril—dilated cardiomyopathy	0.000395	0.00676	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000392	0.00103	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000391	0.00103	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000385	0.00101	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000376	0.000988	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000376	0.000988	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000371	0.000974	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000371	0.000974	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000365	0.00096	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AGT—dilated cardiomyopathy	0.000358	0.00094	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GPX1—dilated cardiomyopathy	0.000351	0.000921	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000348	0.000914	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000347	0.000911	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CD36—dilated cardiomyopathy	0.000342	0.000897	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000341	0.000897	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000337	0.000884	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000335	0.00088	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000335	0.00088	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AGT—dilated cardiomyopathy	0.000332	0.000873	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AGT—dilated cardiomyopathy	0.00032	0.000841	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AGT—dilated cardiomyopathy	0.00032	0.000841	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AGT—dilated cardiomyopathy	0.000308	0.000808	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000304	0.000799	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000298	0.000783	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000291	0.000763	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000269	0.000707	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000268	0.000704	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000258	0.000677	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000258	0.000677	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000257	0.000676	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000249	0.000655	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	0.000234	0.000616	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000234	0.000615	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000231	0.000606	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000222	0.000583	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000222	0.000583	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	0.000212	0.000557	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000202	0.00053	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000178	0.000469	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000177	0.000465	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000166	0.000437	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000158	0.000416	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000152	0.0004	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000152	0.0004	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.00015	0.000395	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000138	0.000363	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000122	0.000322	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000116	0.000304	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000109	0.000286	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	9.83e-05	0.000258	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	5.76e-05	0.000151	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	5.61e-05	0.000147	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	5.05e-05	0.000133	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	4.09e-05	0.000107	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.98e-05	0.000105	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	3.58e-05	9.41e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.67e-05	7.02e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.6e-05	6.84e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.34e-05	6.15e-05	CbGpPWpGaD
